An observational study in Obesity, Morbid, Insulin Sensitivity and Bariatric Surgery Candidate, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). Recruiting at 3 sites in Netherlands. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-08-14.
Sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 31 studies in Obesity, Morbid with a site in Netherlands — 2 open to participants now, 7 under way, none of them phase 3. Obesity, Morbid · Netherlands.
Among the 31 studies in Obesity, Morbid with a site in Netherlands, this one is one of 3 that started in 2023, is one of 7 observational ones, and was the 31st registered.
941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.
Browse Obesity, Morbid studies →2 of the 31 studies in Obesity, Morbid with a site in Netherlands are open now. Recruiting first, the newest first:
St. Antonius Hospital · Sites in Netherlands
Ages 18–65
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
31 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 3 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,200 is above the median of 80 across 311 observational studies indexed under Obesity, Morbid.
Median enrollment 90 across the 24 interventional studies, 35 across the 7 observational. Of the 19 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 31 have an industry lead sponsor. The 10 most frequent:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is the lead sponsor of 533 studies on the registry; 182 are open to participants now.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) has 1 study filed under Obesity, Morbid — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 31 studies in Obesity, Morbid with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In this prospective study the investigators aim to identify preoperative predictors of improvement of metabolic health and weight loss after bariatric surgery focusing on inflammation, insulin sensitivity (in a subgroup of patients), glucoregulatory determinants, psychological traits, feeding behavior characteristics and cardiorespiratory fitness
Obesity is the result of a complex interplay between genetic and epigenetic predisposition, environment, physical activity, nutrition and psychology. It is a debilitating disorder and a risk factor for the development of metabolic disorders such as dyslipidaemia, hypertension and hyperglycaemia as well as certain cancers. Bariatric surgery has proven to be the most effective treatment for morbid obesity with established long-term results of weight loss, remission of comorbid conditions and the improvement of Quality of Life (QoL). However, variability in these results after bariatric surgery is well known. Identifying preoperative predictors of postoperative weight loss and metabolic health is of clinical priority. Predictors could help further improve the efficacy of care for obesity by tailoring treatment to the individual, based on their predicted response and therefore optimize outcome after bariatric surgery.
Patients of the Nederlandse Obesitas Kliniek (Dutch Obesity Clinic).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
In order to be eligible to participate in the subgroup of this study, we will use the following inclusion criteria:
Exclusion Criteria:
A potential subject who meet the following criteria will be excluded from participation in the subgroup of this study:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Postmenopausal
Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Predictors of improvement in metabolic health - insulin sensitivity
HOMA-IR
Time frame: Baseline up to 5 years after surgery
Predictors of improvement in metabolic health - level of glucose control
HbA1C (mmol/mol)
Time frame: Baseline up to 5 years after surgery
Predictors of improvement in metabolic health - glucose
Fasting glucose (mmol/L)
Time frame: Baseline up to 5 years after surgery
Predictors of improvement in metabolic health - insulin
Insulin (pmol/L)
Time frame: Baseline up to 5 years after surgery
Predictors of improvement in metabolic health - lipid profile
Lipids (mmol/L)
Time frame: Baseline up to 5 years after surgery
Predictors of improvement in metabolic health - biomarker inflammation
CRP (mg/L)
Time frame: Baseline up to 5 years after surgery
Predictors of improvement in metabolic health
Genetic variants using GWAS analysis
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss
Genetic variants using GWAS analysis
Time frame: Baseline up to 5 years after surgery
Psychological factors - depression
Patient-Reported Outcomes Measurement Information System Depression (PROMIS-D: validated questionnaire for bariatric surgery. PROMIS-D: range in score from 8 to 40, higher scores indicating greater severity of depression
Time frame: Baseline up to 5 years after surgery
Psychological factors - anxiety
Patient-Reported Outcomes Measurement Information System Anxiety (PROMIS-A): validated questionnaire for bariatric surgery. PROMIS-A: range in score from 7 to 35, higher scores indicating greater severity of anxiety.
Time frame: Baseline up to 5 years after surgery
Psychological factors - impulsivity
Measurements of impulsiveness Barret Impulsiveness Scale (BIS): validated questionnaire to assess level of impulsivity BIS-11: The total scores can range from 30 to 120. Higher scores on the BIS reflect higher levels of impulsiveness.
Time frame: Baseline up to 5 years after surgery
Psychological factors - impulsivity
Measurements of impulsiveness Iowa Gambling Task: validated task to study impulsive behaviour Iowa gambling task: The net score is calculated by subtracting the number of disadvantageous selections from the advantageous selections. A positive net score indicates better performance
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - food addiction
Food addiction scale (YFAS 2.0): validated questionnaire to assess food addiction. YFAS 2.0 includes two scoring methods, a continuous symptom count and a diagnosis of food addiction. Continious symptom count ranges from zero to eleven, Diagnosis of food addiction: no food addiction (0-1 symptoms), a mild food addicition (2-3 symptoms), a moderate food addiction (4-5 symptoms), or a severe food addiction (\>6 symptoms).
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - eating behaviour
Dutch Eating Behaviour Questionnaire (DEBQ): validated questionnaire to assess eating behaviour. DEBQ consists of 33 items.Items on the DEBQ range from 1 (never) to 5 (very often), with higher scores indicating greater endorsement of the eating behavior.
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - Quality of Life
Selfesteem scale of Impact of Weight on Quality of Life - lite (IWQOL-lite): validated questionnaire after weight loss interventions. The self-esteem scale consists of 7 items. Each item is rated on a 5-point scale. Higher scores represent better quality of life.
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - Quality of Life
OBESI-Q (Obesity): validated questionnaire for reporting Health Related Quality of Life. Outcome is expressed on a 100 point scale, a higher score is higher quality of life, with the exception of item "Excess skin".
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - Quality of Life
EuroQuality of Life (EQ-5D): validated questionnaire for reporting Quality of Life after bariatric surgery. Each item is rated on a 5-point scale. Higher scores represent lower reported quality of life.
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - Impulsivity
Measurements of impulsiveness Barret Impulsiveness Scale (BIS): validated questionnaire to assess level of impulsivity BIS-11: The total scores can range from 30 to 120. Higher scores on the BIS reflect higher levels of impulsiveness.
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - Impulsivity
Measurements of impulsiveness Iowa Gambling Task: validated task to study impulsive behaviour Iowa gambling task: The net score is calculated by subtracting the number of disadvantageous selections from the advantageous selections. A positive net score indicates better performance
Time frame: Baseline up to 5 years after surgery
Predictors of weight loss - Physical activity
Short Questionnaire to Assess Health Enhancing Physical Activity (SQUASH): validated questionnaire to assess physical activity. The SQUASH measures the frequency, duration and intensity of 5 different physical activities: commuting (traveling to and from work/study), housekeeping , activities at work, leisure time, and sports. A higher score = more time spend on physical activities.
Time frame: Baseline up to 5 years after surgery
Sexual dimorphism in weight loss
Males versus females regarding weight loss (kg) and percentage of total weight loss
Time frame: Baseline up to 5 years after surgery
Sexual dimorphism in restoration of metabolic health - insulin sensitivity
Males versus females regarding insulin sensitivity (HOMA-IR) and measurements of glucose and insuline
Time frame: Baseline up to 5 years after surgery
Sexual dimorphism in restoration of metabolic health - improvement of diabetes
Males versus females regarding HbA1c values and diabetic drug use
Time frame: Baseline up to 5 years after surgery
Sexual dimorphism in restoration of metabolic health - lipid
Males versus females regarding lipids (mmol/L) and lipid-lowering agents use
Time frame: Baseline up to 5 years after surgery
Sexual dimorphism in restoration of metabolic health - hypertension
Males versus females regarding blood pressure (mmHg) and anithypertensive medication use
Time frame: Baseline up to 5 years after surgery
Peripheral insulin sensitivity
In a subset of 40 patients insulin sensitivity will be assessed using hyperinsulinemic euglycemic clamps, and adipose tissue and skeletal muscle biopsies will be taken to assess insulin signalling (expression of mRNA and phosphorylated proteins)
Time frame: Before and 3 and 18 months after bariatric surgery
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2023 (actual). Primary completion is estimated for Aug 2024, 19 months after the start.
Of 138 non-industry observational studies under Obesity, Morbid, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 132. This study's planned 19 months is below that.
Counting every sponsor, half of 139 studies reached it within 46 months; a quarter within 16 and three quarters within 132.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) →